Deepak Nitrite Ltd: Is This Chemical Romance Still Strong or Just Fading Fumes?

1. At a Glance

Deepak Nitrite Ltd, once the poster boy of specialty chemicals in India, has seen margin compression, capex splurges, and investor emotions swing like a pendulum. From explosive multibagger to “meh”, is DNL still a compounder or just a cautionary tale?

2. Introduction with Hook

Imagine you’re at a party and someone yells “multibagger!” — back in 2020-21, chances were they were talking about Deepak Nitrite. But like every viral sensation, it now sits nursing a soda in the corner while others dance.

• Sales: ₹8,282 Cr in FY25 (flat for 2 years)
• Net Profit: ₹697 Cr (down from ₹1,067 Cr in FY22)
• ROCE: 17% (once upon a time, was 44%)
• Stock down ~29% in 1 year

When your P&L goes from phenol to phone-it-in, something’s up.

3. Business Model (WTF Do They Even Do?)

DNL operates in three main verticals:

1. Basic Intermediates – Acetone, Nitro Toluene etc.
2. Fine & Specialty Chemicals – Pharma & agro intermediates
3. Performance Products – Xylidines, Cumidines
4. Phenolics (through 100% subsidiary DPL) – Phenol, Acetone, IPA

Phenolics contribute ~60% to revenue, but are margin-light. Specialty chemicals are margin kings, but slower to scale.

Customers range from pharma giants to agro-chem firms and FMCG titans. But pricing power? That’s now just a fond memory.

4. Financials Overview